Study links statins to reduced cancer-related deaths

11/8/2012 | Reuters

Cancer patients receiving statins, a class of cholesterol-lowering drugs, were 15% less likely to die of cancer or of other causes than those who weren't taking the medications, according to a Danish study published in the New England Journal of Medicine. "Statin use in patients with cancer is associated with reduced cancer-related mortality," researchers said. "Our hypothesis is that by reducing cholesterol, you steal cholesterol from the proliferating cancer cells ... improving survival," lead researcher Stig Bojesen said.

View Full Article in:


Published in Briefs: